Skip to main content
OpenTrials
Completed

NCT Number: NCT05433519

Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age

This is a prospective cohort study of women enrolled early in pregnancy, with randomization to determine the timing of three follow-up visits in the second and third trimester. At each of these follow-up visits, investigators will assess gestational age with the FAMLI technology and compare that estimate to the known gestational age established early in pregnancy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–59 year

Sex eligibility

Female

Study type

Observational

Primary location

University of North Carolina, Chapel Hill, North Carolina, United States

Loading trial locations.

About this study

The primary purpose of this research is to assess the diagnostic accuracy of the FAMLI Technology, a novel machine learning-based tool for gestational age assessment that can run on a smart phone or tablet. Study staff will enroll 400 pregnant volunteers prior to 14 completed gestational weeks and obtain accurate "ground truth" gestational age dating with standard ultrasound biometry, using the crown-rump length. These participants will then be asked to return for three follow-up visits, which will include a routine sonogram performed by a trained sonographer and the collection of a set of blind sweep cineloop videos using a low-cost, battery-operated device. The research will be conducted in Chapel Hill, North Carolina (at the University of North Carolina Hospital and/or sites associated with UNC OBGYN) and in Lusaka, Zambia (at the University Teaching Hospital or Kamwala District Health Centre). Approximately equal numbers of participants will be enrolled from each country.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • viable intrauterine pregnancy at less than 14 0/7 weeks of gestation
  • ability and willingness to provide written informed consent
  • intent to remain in current geographical area of residence for the duration of study
  • willingness to adhere to study procedures

Exclusion criteria

  • maternal body mass index = 40 kg/m^2
  • multiple gestation (i.e., twins or higher order)
  • major fetal malformation or anomaly
  • any other condition (social or medical) that, in the opinion of the study staff, would make study participation unsafe or complicate data interpretation.

Treatment and study plan

Primary outcomes

  1. Diagnostic accuracy of FAMLI Technology

    Time frame: From 14 through 27 completed weeks of gestation

    Difference in mean absolute error (MAE) of the index test and clinical reference standard in the primary evaluation window

Secondary outcomes

  1. Mean absolute error in the secondary evaluation window

    Time frame: From 28 through 36 completed weeks of gestation

    Difference in mean absolute error (MAE) of the index test and clinical reference standard in the secondary evaluation window

Sponsors and collaborators

Lead sponsor

University of North Carolina, Chapel Hill

Other

Collaborators

  • Bill and Melinda Gates Foundation

Registry information

Official study title

Z 32104 - Diagnostic Accuracy of a Novel Machine Learning Algorithm to Estimate Gestational Age

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jun 27, 2022
Registry last updated
May 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.